389 related articles for article (PubMed ID: 10202929)
1. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.
Fernandez NC; Lozier A; Flament C; Ricciardi-Castagnoli P; Bellet D; Suter M; Perricaudet M; Tursz T; Maraskovsky E; Zitvogel L
Nat Med; 1999 Apr; 5(4):405-11. PubMed ID: 10202929
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the anti-tumor function of adoptively transferred NK cells in vivo.
Pegram HJ; Haynes NM; Smyth MJ; Kershaw MH; Darcy PK
Cancer Immunol Immunother; 2010 Aug; 59(8):1235-46. PubMed ID: 20376439
[TBL] [Abstract][Full Text] [Related]
3. Broad antitumor protection by dendritic cells administered to CD8alpha knock out mice.
Ribas A; Vo DD; Weeks DL; Comin-Anduix B; Schumacher LY; Garban HJ; McLean C; Yang J; Dissette VB; Peraza P; Owens SK; McBride WH; Glaspy JA; Economou JS
Cancer Immunol Immunother; 2006 Jun; 55(6):663-71. PubMed ID: 16133107
[TBL] [Abstract][Full Text] [Related]
4. Natural resistance mechanisms may play a role in protection against chemical carcinogenesis.
Brodt P; Gordon J
Cancer Immunol Immunother; 1982; 13(2):125-7. PubMed ID: 6984356
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal activating interaction between natural killer cells and dendritic cells.
Gerosa F; Baldani-Guerra B; Nisii C; Marchesini V; Carra G; Trinchieri G
J Exp Med; 2002 Feb; 195(3):327-33. PubMed ID: 11828007
[TBL] [Abstract][Full Text] [Related]
6. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells.
Piccioli D; Sbrana S; Melandri E; Valiante NM
J Exp Med; 2002 Feb; 195(3):335-41. PubMed ID: 11828008
[TBL] [Abstract][Full Text] [Related]
7. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs.
Ferlazzo G; Pack M; Thomas D; Paludan C; Schmid D; Strowig T; Bougras G; Muller WA; Moretta L; Münz C
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16606-11. PubMed ID: 15536127
[TBL] [Abstract][Full Text] [Related]
8. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming.
Martín-Fontecha A; Thomsen LL; Brett S; Gerard C; Lipp M; Lanzavecchia A; Sallusto F
Nat Immunol; 2004 Dec; 5(12):1260-5. PubMed ID: 15531883
[TBL] [Abstract][Full Text] [Related]
9. Immunobiology of dendritic cells.
Banchereau J; Briere F; Caux C; Davoust J; Lebecque S; Liu YJ; Pulendran B; Palucka K
Annu Rev Immunol; 2000; 18():767-811. PubMed ID: 10837075
[TBL] [Abstract][Full Text] [Related]
10. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells.
Ferlazzo G; Tsang ML; Moretta L; Melioli G; Steinman RM; Münz C
J Exp Med; 2002 Feb; 195(3):343-51. PubMed ID: 11828009
[TBL] [Abstract][Full Text] [Related]
11. NK cell and DC interactions.
Cooper MA; Fehniger TA; Fuchs A; Colonna M; Caligiuri MA
Trends Immunol; 2004 Jan; 25(1):47-52. PubMed ID: 14698284
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk.
Fernandez NC; Flament C; Crépineau F; Angevin E; Vivier E; Zitvogel L
Eur Cytokine Netw; 2002; 13(1):17-27. PubMed ID: 11956017
[TBL] [Abstract][Full Text] [Related]
13. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs.
Borg C; Jalil A; Laderach D; Maruyama K; Wakasugi H; Charrier S; Ryffel B; Cambi A; Figdor C; Vainchenker W; Galy A; Caignard A; Zitvogel L
Blood; 2004 Nov; 104(10):3267-75. PubMed ID: 15242871
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells prime natural killer cells by trans-presenting interleukin 15.
Lucas M; Schachterle W; Oberle K; Aichele P; Diefenbach A
Immunity; 2007 Apr; 26(4):503-17. PubMed ID: 17398124
[TBL] [Abstract][Full Text] [Related]
15. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1.
Semino C; Angelini G; Poggi A; Rubartelli A
Blood; 2005 Jul; 106(2):609-16. PubMed ID: 15802534
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cells and dendritic cells: rendezvous in abused tissues.
Moretta A
Nat Rev Immunol; 2002 Dec; 2(12):957-64. PubMed ID: 12461568
[TBL] [Abstract][Full Text] [Related]
17. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor.
Vitale M; Della Chiesa M; Carlomagno S; Pende D; Aricò M; Moretta L; Moretta A
Blood; 2005 Jul; 106(2):566-71. PubMed ID: 15784725
[TBL] [Abstract][Full Text] [Related]
18. Emerging strategies for treating autoimmune disease with genetically modified dendritic cells.
Ma Y; Shi R; Li F; Chang H
Cell Commun Signal; 2024 May; 22(1):262. PubMed ID: 38715122
[TBL] [Abstract][Full Text] [Related]
19. Late-Stage Ovarian Cancer With Systemic Multiple Metastases Shows Marked Shrinkage Using a Combination of Wilms' Tumor Antigen 1 (WT1) Dendritic Cell Vaccine, Natural Killer (NK) Cell Therapy, and Nivolumab.
Nagai H; Karube R
Cureus; 2024 Mar; 16(3):e56685. PubMed ID: 38523872
[TBL] [Abstract][Full Text] [Related]
20. Actin cytoskeleton remodeling at the cancer cell side of the immunological synapse: good, bad, or both?
Ockfen E; Filali L; Pereira Fernandes D; Hoffmann C; Thomas C
Front Immunol; 2023; 14():1276602. PubMed ID: 37869010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
